If you’ve seen or read the news in the past couple of years, you’ve probably heard about the “miracle” weight loss drugs like Ozempic, Wegovy, and Mounjaro. For many of us over 50, these GLP-1 ...
Monlunabant, a novel cannabinoid receptor 1 (CB1R) inverse agonist, led to significant weight loss compared with placebo in patients with obesity and metabolic syndrome over 16 weeks; however, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results